Printability of pharmaceutical Fused Deposition Modeling (FDM) feedstock material: mechanical characterisation of FDM filaments and the FDM 3D printing process

Research output: Contribution to conferencePosterpeer-review

3 Downloads (Pure)

Abstract

Purpose -- 3D printing (3DP) of pharmaceutical formulations via commercially available FDM printers facilitates advanced control of the microstructure of the tablet core and therefore drug release properties. For this 3DP process an intermediate feedstock material is manufactured and used in the FDM process.
However, mechanical and rheological properties of pharmaceutically approved polymers are often not suitable for this process. In order to identify suitable filaments for the FDM process, the objective of this study was to perform a mechanical and rheological characterisation of the feedstock material during an FDM process.

Conclusions -- Mechanical properties of an FDM process for commercial and in-house prepared pharmaceutically relevant feed stock material were investigated and have shown the material dependant impact of print geometries and print speed on the FDM process; informing future development of pharmaceutically relevant feedstock material.
Original languageEnglish
Publication statusPublished - 16 Oct 2022
EventAAPS 2022 Pharm Sci 360 - USA, Boston, United States
Duration: 16 Oct 202219 Oct 2022
https://www.aaps.org/pharmsci/annual-meeting

Conference

ConferenceAAPS 2022 Pharm Sci 360
Country/TerritoryUnited States
CityBoston
Period16/10/2219/10/22
Internet address

Keywords

  • 3D printing (3DP)
  • drug release properties

Fingerprint

Dive into the research topics of 'Printability of pharmaceutical Fused Deposition Modeling (FDM) feedstock material: mechanical characterisation of FDM filaments and the FDM 3D printing process'. Together they form a unique fingerprint.

Cite this